Acadia Pharmaceuticals (ACAD +1.3%) says it receiving funding from Fast Forward, LLC, a...
Acadia Pharmaceuticals (ACAD +1.3%) says it receiving funding from Fast Forward, LLC, a not-for-profit organization established by the National Multiple Sclerosis Society, and EMD Serono, a subsidiary of Merck KGaA (MCGAY.PK). The funding will go to support R&D directed at using AC-186, ACAD’s estrogen receptor (ER)-beta agonist, as a new approach to the treatment of multiple sclerosis.
From other sites
at Nasdaq.com (Mar 27, 2015)
at 4-traders.com (Mar 23, 2015)
at Zacks.com (Mar 13, 2015)
at MarketWatch.com (Mar 11, 2015)
at CNBC.com (Mar 11, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs